• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生黑猩猩基于核酸的乙型肝炎病毒免疫接种成功。

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus.

作者信息

Prince A M, Whalen R, Brotman B

机构信息

Laboratory of Virology and Parasitology, Lindsley F. Kimball Research Institute of the New York Blood Center, NY 10021, USA.

出版信息

Vaccine. 1997 Jun;15(8):916-9. doi: 10.1016/s0264-410x(96)00248-4.

DOI:10.1016/s0264-410x(96)00248-4
PMID:9234547
Abstract

To determine whether DNA based immunization could protect newborn chimpanzees against a challenge infection with hepatitis B virus, two chimpanzees were immunized on the day of birth with a plasmid coding for hepatitis B surface antigen, and boosted at 6 and 24 weeks. Both animals produced transient antibody to the hepatitis B surface antigen. Following challenge with hepatitis B virus at 33 weeks the two immunized animals developed anamnestic antibody responses, however, neither developed detectable hepatitis B surface antigen or antibody to the core protein, the conventional markers of hepatitis B infection. Both of these markers appeared in an unimmunized control animal. We conclude that DNA based immunization can induce protective immunity in newborn chimpanzees.

摘要

为了确定基于DNA的免疫接种能否保护新生黑猩猩免受乙型肝炎病毒的攻击感染,两只黑猩猩在出生当天用编码乙型肝炎表面抗原的质粒进行免疫接种,并在6周和24周时进行加强免疫。两只动物均产生了针对乙型肝炎表面抗原的短暂抗体。在33周时用乙型肝炎病毒进行攻击后,两只免疫接种的动物产生了回忆性抗体反应,然而,两者均未出现可检测到的乙型肝炎表面抗原或核心蛋白抗体,而这些是乙型肝炎感染的传统标志物。这两种标志物均出现在一只未免疫接种的对照动物中。我们得出结论,基于DNA的免疫接种可在新生黑猩猩中诱导保护性免疫。

相似文献

1
Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus.新生黑猩猩基于核酸的乙型肝炎病毒免疫接种成功。
Vaccine. 1997 Jun;15(8):916-9. doi: 10.1016/s0264-410x(96)00248-4.
2
Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.对经CpG优化的蛋白质和DNA疫苗进行黑猩猩乙型肝炎病毒免疫原性测试及攻毒保护试验。
Intervirology. 2006;49(3):144-51. doi: 10.1159/000089375.
3
DNA-based immunization against hepatitis B virus.基于DNA的乙型肝炎病毒免疫接种
Springer Semin Immunopathol. 1997;19(2):195-209. doi: 10.1007/BF00870268.
4
Comparing the immunogenicity of hepatitis B virus S gene variants by DNA immunization.通过DNA免疫比较乙型肝炎病毒S基因变异体的免疫原性。
Viral Immunol. 2001;14(4):359-67. doi: 10.1089/08828240152716600.
5
Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.获得许可的重组乙型肝炎疫苗可保护黑猩猩免受乙型肝炎病毒原型表面基因突变体的感染。
Hepatology. 1999 Sep;30(3):779-86. doi: 10.1002/hep.510300309.
6
Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.给黑猩猩输注高传染性血液后乙肝疫苗的疗效。
J Infect Dis. 1983 Feb;147(2):327-35. doi: 10.1093/infdis/147.2.327.
7
[Reciprocal priming-boosting role of HBsAg and DNA vaccines].[乙肝表面抗原(HBsAg)与DNA疫苗的相互启动-增强作用]
Zhonghua Gan Zang Bing Za Zhi. 2003 Apr;11(4):212-4.
8
The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.乙肝表面抗原DNA疫苗引发细胞介导免疫反应而非抗体反应的能力受到S抗原去糖基化的影响。
Vaccine. 2008 Sep 19;26(40):5145-52. doi: 10.1016/j.vaccine.2008.03.072. Epub 2008 Apr 18.
9
The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen.
Postgrad Med J. 1987;63 Suppl 2:93-6.
10
Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.一种通过商用原型设备经皮给药的乙肝核酸粉末状疫苗的临床安全性和有效性
Vaccine. 2005 Sep 23;23(40):4867-78. doi: 10.1016/j.vaccine.2005.05.026.

引用本文的文献

1
Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection.慢性乙型肝炎病毒感染治疗性疫苗研发的当前进展
Iran J Basic Med Sci. 2016 Jul;19(7):692-704.
2
The chimpanzee model for hepatitis B virus infection.乙型肝炎病毒感染的黑猩猩模型。
Cold Spring Harb Perspect Med. 2015 Jun 1;5(6):a021469. doi: 10.1101/cshperspect.a021469.
3
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.鼻腔内 DNA 疫苗预防呼吸道传染病:传递视角。
Pharmaceutics. 2014 Jul 10;6(3):378-415. doi: 10.3390/pharmaceutics6030378.
4
Technologies for enhanced efficacy of DNA vaccines.增强 DNA 疫苗效力的技术。
Expert Rev Vaccines. 2012 Feb;11(2):189-209. doi: 10.1586/erv.11.188.
5
FDA guidance on prophylactic DNA vaccines: analysis and recommendations.FDA 关于预防性 DNA 疫苗的指南:分析与建议。
Vaccine. 2010 Apr 1;28(16):2801-5. doi: 10.1016/j.vaccine.2009.11.025. Epub 2009 Nov 24.
6
Hepatocellular carcinoma: therapy and prevention.肝细胞癌:治疗与预防
World J Gastroenterol. 2005 Dec 21;11(47):7391-400. doi: 10.3748/wjg.v11.i47.7391.
7
Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.用表达与细胞毒性T淋巴细胞相关抗原4融合的土拨鼠肝炎病毒核衣壳蛋白的基因进行免疫,可增强小鼠和土拨鼠的特异性免疫反应。
J Virol. 2005 May;79(10):6368-76. doi: 10.1128/JVI.79.10.6368-6376.2005.
8
Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.柯萨奇病毒B3与新生儿中枢神经系统:干细胞、发育中的神经元以及细胞凋亡在感染、病毒传播和疾病中的作用
Am J Pathol. 2003 Oct;163(4):1379-93. doi: 10.1016/S0002-9440(10)63496-7.
9
Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update.用于免疫预防的甲型肝炎、乙型肝炎及联合肝炎疫苗:最新进展
Dig Dis Sci. 2002 Jun;47(6):1183-94. doi: 10.1023/a:1015397807278.
10
Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.通过转输来自用1型人类T细胞白血病病毒Tax编码DNA疫苗免疫的供体的T细胞预防大鼠成年T细胞白血病样淋巴细胞增殖性疾病
J Virol. 2000 Oct;74(20):9610-6. doi: 10.1128/jvi.74.20.9610-9616.2000.